2.2.3 Potassium-sparing diuretics and aldosterone antagonists

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

34 library items in 2.2.3 Potassium-sparing diuretics and aldosterone antagonists

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

2: Cardiovascular system (remove) , 2.2 Diuretics (remove) , 2.2.3 Potassium-sparing diuretics and aldosterone (remove)

Sort by: Display summary:

Results 1 - 10 of 34

Result page:
Previous
|
1
2
3
4
|
Next

1.

Subgroup analysis of EMPHASIS-HF trial shows patients on eplerenone less likely to suffer atrial fibrillation or flutter

Source: Journal of the American College of Cardiology,
Date published: 30/04/2012

Category:

2.2.3 Potassium-sparing diuretics and aldosterone antagonists | Heart Failure

NeLM Area:

News

Abstract
2.

Inspra (eplerenone) tablets - Revised SPC

Source: eMC (electronic Medicines Compendium),
Date published: 19/04/2012

Category:

2.2.3 Potassium-sparing diuretics and aldosterone antagonists | Heart Failure

NeLM Area:

Other Library Updates > SPC Changes

SPC
3.

Co-trimoxazole and spironolactone co-prescription increases risk of serious hyperkalaemia and should be avoided

Source: British Medical Journal,
Date published: 13/09/2011

Category:

2.2.3 Potassium-sparing diuretics and aldosterone antagonists | 5.1.8 Sulphonamides and trimethoprim | Adverse Drug Reactions | Nutrition and Metabolism

NeLM Area:

News

Link (abstract)

Editorial (extract)
4.

Aldactone 25mg, 50mg & 100mg tablets (spironolactone) - Revised SPC

Source: Manufacturer notification,
Date published: 08/09/2011

Category:

2.2.3 Potassium-sparing diuretics and aldosterone antagonists

NeLM Area:

Other Library Updates > SPC Changes

SPC
5.

Review: Mineralocorticoid receptor antagonism in acute heart failure syndromes

Source: European Heart Journal,
Date published: 15/06/2011

Category:

2.2.3 Potassium-sparing diuretics and aldosterone antagonists | Heart Failure

NeLM Area:

News

Abstract
6.

Conference report: Addition of eplerenone (Inspra®) to standard therapy in AF – sub-analysis of the EMPHASIS-HF study

Source: BioSpace,
Date published: 24/05/2011

Category:

2.2.3 Potassium-sparing diuretics and aldosterone antagonists | Heart Failure

NeLM Area:

News

Link
7.

Cohort study: Spironolactone use at discharge associated with improved survival in hospitalised patients with systolic heart failure

Source: American Heart Journal,
Date published: 05/01/2011

Category:

2.2.3 Potassium-sparing diuretics and aldosterone antagonists | Heart Failure

NeLM Area:

News

Abstract
8.

Eplerenone of benefit when added to standard therapy for heart failure with mild symptoms?

Source: New England Journal of Medicine (NEJM),
Date published: 15/11/2010

Category:

2.2.3 Potassium-sparing diuretics and aldosterone antagonists | Heart Failure

NeLM Area:

News

Link (abstract)

NPCi Blog
9.

Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure

Source: Clinical Pharmacology and Therapeutics,
Date published: 05/10/2010

Category:

2.2.3 Potassium-sparing diuretics and aldosterone antagonists | 2.4 Beta-adrenoceptor blocking drugs | 2.5.5 Drugs affecting the renin-angiotensin system | Care of Older People | Compliance | Heart Failure

NeLM Area:

Evidence > Medicines Management > References

Abstract link
10.

Spironolactone for hypertension

Source: Cochrane Library,
Date published: 18/08/2010

Category:

2.2.3 Potassium-sparing diuretics and aldosterone antagonists | Drug reviews | Hypertension

NeLM Area:

Evidence > Drug Specific Reviews

Link

Results 1 - 10 of 34

Result page:
Previous
|
1
2
3
4
|
Next